Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial

被引：0
|
作者：
Eggert Stockfleth
Ralph von Kiedrowski
Rolf Dominicus
John Ryan
Adam Ellery
Meritxell Falqués
Nathalie Ivanoff
Rosario Rodriguez Azeredo
机构：
[1] Ruhr-University,Department of Dermatology
[2] Dermatological Practice,undefined
[3] Proderma,undefined
[4] The Alverton Practice,undefined
[5] Cape Cornwall Surgery,undefined
[6] Almirall S.A.,undefined
来源：
Dermatology and Therapy | 2017年 / 7卷
关键词：
Actinic keratosis; Field cancerization; Field-directed treatment; 5-Fluorouracil/salicylic acid; Hyperkeratotic lesion; Topical treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 96
页数：15
相关论文
共 50 条
  • [11] Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials
    Lebwohl, M
    Dinehart, MB
    Whiting, D
    Lee, PK
    Tawfik, N
    Jorizzo, J
    Lee, JH
    Fox, TL
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (05) : 714 - 721
  • [12] Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain
    Nieves, Diana
    Puig-Peiro, Ruth
    Ferrandiz, Carlos
    Josep Plazas, Maria
    Brosa, Max
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (03) : 539 - 543
  • [13] Single-blind, randomized controlled trial to evaluate the efficacy and safety of photodynamic therapy using aminolevulinic acid versus 5-fluorouracil in the management of actinic keratosis
    Gupta, AK
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P129 - P129
  • [14] Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery - A randomized, vehicle-controlled clinical trial
    Jorizzo, J
    Weiss, J
    Furst, K
    VandePol, C
    Levy, SF
    ARCHIVES OF DERMATOLOGY, 2004, 140 (07) : 813 - 816
  • [15] A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses
    Stockfleth, E
    Meyer, T
    Benninghoff, B
    Salasche, S
    Papadopoulos, L
    Ulrich, C
    Christophers, E
    ARCHIVES OF DERMATOLOGY, 2002, 138 (11) : 1498 - 1502
  • [16] Treatment monitoring of 5-fluorouracil 0.5%/salicylic acid 10% lesion-directed therapy for actinic keratosis using dermoscopy and in-vivo reflectance confocal microscopy
    Pampena, Riccardo
    Condorelli, Alessandra
    Cornacchia, Luigi
    Guiducci, Laura
    Raucci, Margherita
    Benati, Elisa
    Mirra, Marica
    Peris, Ketty
    Lai, Michela
    Pellacani, Giovanni
    Longo, Caterina
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [17] The efficacy and safety of diclofenac 3% gel treatment of multiple actinic keratoses in organ transplant patients: A double-blind, randomized, vehicle-controlled study
    Ulrich, Claas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB107 - AB107
  • [18] A Phase 3 Randomized, Double-blind, Vehicle-Controlled Trial of Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea
    Draelos, Zoe Diana
    Elewski, Boni E.
    Harper, Julie C.
    Sand, Meike
    Staedtler, Gerald
    Nkulikiyinka, Richard
    Shakery, Kaweh
    CUTIS, 2015, 96 (01): : 54 - 61
  • [19] A randomized, double-blind, vehicle-controlled study of diclofenac 3% in hyaluronic acid 2.5% gel for the treatment of actinic keratoses
    Dessinioti, C.
    Panagiotopoulos, A.
    Verra, P.
    Papagiannaki, N.
    Stavropoulos, P.
    Katsambas, A.
    Antoniou, C.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E12 - E12
  • [20] A Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Naftifine 2% Cream in the Treatment of Tinea Pedis
    Parish, Lawrence Charles
    Parish, Jennifer L.
    Routh, Hirak B.
    Fleischer, Alan B., Jr.
    Avakian, Edward V.
    Plaum, Stefan
    Hardas, Bhushan
    JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (11) : 1282 - 1288
12345